Tak-Wah Mak

Tak-Wah Mak

Founder at
Tio Bioventures
79 year
Health Technology
Consumer Services
Commercial Services

Profile

Tak-Wah Mak is the founder of Agios Pharmaceuticals, Inc., founded in 2007.
Dr. Mak is the founder of Treadwell Therapeutics, Inc., founded in 2019.
Dr. Mak is also the founder of Tio Bioventures..
Dr. Mak is Director & Chief Scientific Officer at Miikana Therapeutics, Inc. since 2002.
Dr. Mak is Director at The Campbell Family Institute for Breast Cancer Research.
Dr. Mak is Professor at the University of Toronto since 2003.
Dr. Mak is Associate at the National Academy of Sciences.
Dr. Mak is Associate at the American Academy of Arts & Sciences.
Dr. Mak was Director at CASI Pharmaceuticals, Inc. from 2012 to 2016.
Dr. Mak was Director at Hong Kong Science & Technology Parks Corp.
Dr. Mak was Director at XBiotech, Inc. Dr. Mak earned a doctorate from the University of Alberta.
Dr. Mak completed undergraduate and graduate degrees at the University of Wisconsin.

Tak-Wah Mak active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 2001-12-31
Corporate Officer/Principal 2002-12-31
The Campbell Family Institute for Breast Cancer Research
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Founder -

Former positions of Tak-Wah Mak

CompaniesPositionEnd
Director/Board Member 2016-06-01
XBIOTECH INC. Director/Board Member -
Founder -
░░░░ ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of Tak-Wah Mak's experience

Training of Tak-Wah Mak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

The Campbell Family Institute for Breast Cancer Research

Health Technology

Finance